Molecular Mistletoe Therapy: Friend or Foe in Established Anti-Tumor Protocols? A Multicenter, Controlled, Retrospective Pharmaco-Epidemiological Study in Pancreas Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1875-5666|10|4|430-439

ISSN： 1566-5240

Source： Current Molecular Medicine, Vol.10, Iss.4, 2010-01, pp. : 430-439

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Apoptosis: friend or foe?

By Fellstrom B.   Zezina L.  

Transplantation Proceedings, Vol. 33, Iss. 3, 2001-05 ,pp. : 2414-2416

Elsevier

Access to resources Recommend Favorite

Viruses: friend or foe?

By Salmons B.  

Trends in Molecular Medicine, Vol. 7, Iss. 4, 2001-04 ,pp. : 185-185

Elsevier

Access to resources Recommend Favorite

Endotoxin: Friend or Foe?

By Liu Andrew H.   Redmon Agile H.  

Allergy and Asthma Proceedings, Vol. 22, Iss. 6, 2001-11 ,pp. : 337-340

OceanSide Publications, Inc

Access to resources Recommend Favorite

The effects of chemotherapy on primary small bowel cancer: A retrospective multicenter observational study in Japan

By                                    

Molecular and Clinical Oncology, Vol. 1, Iss. 5, 2013-01 ,pp. : 820-824

Spandidos Publications

Access to resources Recommend Favorite

Comparison of the Anti-Tumor Effects of Various Whole-Body Hyperthermia Protocols: Correlation with HSP 70 Expression and Composition of Splenic Lymphocytes

By Zhang Honghai   Wang Weirong   Zhang Shuhong   Huang Weida  

Immunological Investigations, Vol. 34, Iss. 3, 2005-08 ,pp. : 245-258

Informa Healthcare

Access to resources Recommend Favorite